Filing Details
- Accession Number:
- 0001209191-22-062647
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-23 17:05:59
- Reporting Period:
- 2022-11-01
- Accepted Time:
- 2022-12-23 17:05:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1684087 | Caroline Young | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-11-01 | 20 | $2.53 | 18,808 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-11-02 | 20 | $2.54 | 18,828 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-11-03 | 20 | $2.44 | 18,848 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-11-04 | 20 | $2.42 | 18,868 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-11-07 | 20 | $2.45 | 18,888 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-11-08 | 20 | $2.42 | 18,908 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-11-09 | 20 | $2.37 | 18,928 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-11-10 | 20 | $2.37 | 18,948 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-11-11 | 20 | $2.32 | 18,968 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-11-14 | 20 | $2.32 | 18,988 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-11-15 | 20 | $2.35 | 19,008 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-11-16 | 20 | $2.31 | 19,028 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-11-17 | 20 | $2.29 | 19,048 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-11-18 | 20 | $2.27 | 19,068 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-11-21 | 20 | $2.38 | 19,088 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-11-22 | 20 | $2.37 | 19,108 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-11-23 | 20 | $2.29 | 19,128 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-11-25 | 20 | $2.31 | 19,148 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-11-28 | 20 | $2.37 | 19,168 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-11-29 | 20 | $2.34 | 19,188 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-11-30 | 20 | $2.32 | 19,208 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.